136 related articles for article (PubMed ID: 24292212)
1. Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.
Pettersson A; Lis RT; Meisner A; Flavin R; Stack EC; Fiorentino M; Finn S; Graff RE; Penney KL; Rider JR; Nuttall EJ; Martin NE; Sesso HD; Pollak M; Stampfer MJ; Kantoff PW; Giovannucci EL; Loda M; Mucci LA
J Natl Cancer Inst; 2013 Dec; 105(24):1881-90. PubMed ID: 24292212
[TBL] [Abstract][Full Text] [Related]
2. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.
Ahearn TU; Peisch S; Pettersson A; Ebot EM; Zhou CK; Graff RE; Sinnott JA; Fazli L; Judson GL; Bismar TA; Rider JR; Gerke T; Chan JM; Fiorentino M; Flavin R; Sesso HD; Finn S; Giovannucci EL; Gleave M; Loda M; Li Z; Pollak M; Mucci LA;
Carcinogenesis; 2018 Dec; 39(12):1431-1437. PubMed ID: 30165429
[TBL] [Abstract][Full Text] [Related]
3. MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer.
Pettersson A; Gerke T; Penney KL; Lis RT; Stack EC; Pértega-Gomes N; Zadra G; Tyekucheva S; Giovannucci EL; Mucci LA; Loda M
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):201-207. PubMed ID: 29141848
[No Abstract] [Full Text] [Related]
4. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.
Ma J; Li H; Giovannucci E; Mucci L; Qiu W; Nguyen PL; Gaziano JM; Pollak M; Stampfer MJ
Lancet Oncol; 2008 Nov; 9(11):1039-47. PubMed ID: 18835745
[TBL] [Abstract][Full Text] [Related]
5. Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study.
Perez-Cornago A; Appleby PN; Pischon T; Tsilidis KK; Tjønneland A; Olsen A; Overvad K; Kaaks R; Kühn T; Boeing H; Steffen A; Trichopoulou A; Lagiou P; Kritikou M; Krogh V; Palli D; Sacerdote C; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Molina-Portillo E; Barricarte A; Chirlaque MD; Quirós JR; Stattin P; Häggström C; Wareham N; Khaw KT; Schmidt JA; Gunter M; Freisling H; Aune D; Ward H; Riboli E; Key TJ; Travis RC
BMC Med; 2017 Jul; 15(1):115. PubMed ID: 28701188
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
Kelly SP; Graubard BI; Andreotti G; Younes N; Cleary SD; Cook MB
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754927
[TBL] [Abstract][Full Text] [Related]
7. Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer.
Kenfield SA; Batista JL; Jahn JL; Downer MK; Van Blarigan EL; Sesso HD; Giovannucci EL; Stampfer MJ; Chan JM
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26577654
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer incidence, clinical stage and survival in relation to obesity: a prospective cohort study in Denmark.
Møller H; Roswall N; Van Hemelrijck M; Larsen SB; Cuzick J; Holmberg L; Overvad K; Tjønneland A
Int J Cancer; 2015 Apr; 136(8):1940-7. PubMed ID: 25264293
[TBL] [Abstract][Full Text] [Related]
9. Sedentary behavior and prostate cancer risk in the NIH-AARP Diet and Health Study.
Lynch BM; Friedenreich CM; Kopciuk KA; Hollenbeck AR; Moore SC; Matthews CE
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):882-9. PubMed ID: 24526287
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol Metabolism and Prostate Cancer Lethality.
Stopsack KH; Gerke TA; Sinnott JA; Penney KL; Tyekucheva S; Sesso HD; Andersson SO; Andrén O; Cerhan JR; Giovannucci EL; Mucci LA; Rider JR
Cancer Res; 2016 Aug; 76(16):4785-90. PubMed ID: 27325648
[TBL] [Abstract][Full Text] [Related]
11. Associations between Etiologic or Prognostic Tumor Tissue Markers and Neighborhood Contextual Factors in Male Health Professionals Diagnosed with Prostate Cancer.
Iyer HS; Kensler KH; Vaselkiv JB; Stopsack KH; Roscoe C; Bandera EV; Qin B; Jang TL; Lotan TL; James P; Hart JE; Mucci LA; Laden F; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1120-1123. PubMed ID: 37249585
[TBL] [Abstract][Full Text] [Related]
12. Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate Cancer.
Zhang Y; Stopsack KH; Wu K; Song M; Mucci LA; Giovannucci E
J Urol; 2023 Mar; 209(3):549-556. PubMed ID: 36453265
[TBL] [Abstract][Full Text] [Related]
13. What is the Need for Prostatic Biomarkers in Prostate Cancer Management?
Spahn M; Boxler S; Joniau S; Moschini M; Tombal B; Karnes RJ
Curr Urol Rep; 2015 Oct; 16(10):70. PubMed ID: 26267226
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study.
J Clin Oncol; 2024 May; 42(15):1864. PubMed ID: 38626362
[No Abstract] [Full Text] [Related]
15. SPINK1 protein expression and prostate cancer progression.
Flavin R; Pettersson A; Hendrickson WK; Fiorentino M; Finn S; Kunz L; Judson GL; Lis R; Bailey D; Fiore C; Nuttall E; Martin NE; Stack E; Penney KL; Rider JR; Sinnott J; Sweeney C; Sesso HD; Fall K; Giovannucci E; Kantoff P; Stampfer M; Loda M; Mucci LA
Clin Cancer Res; 2014 Sep; 20(18):4904-11. PubMed ID: 24687926
[TBL] [Abstract][Full Text] [Related]
16. Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.
Egbers L; Luedeke M; Rinckleb A; Kolb S; Wright JL; Maier C; Neuhouser ML; Stanford JL
Am J Epidemiol; 2015 May; 181(9):706-13. PubMed ID: 25852077
[TBL] [Abstract][Full Text] [Related]
17. Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues.
Tyekucheva S; Martin NE; Stack EC; Wei W; Vathipadiekal V; Waldron L; Fiorentino M; Lis RT; Stampfer MJ; Loda M; Parmigiani G; Mucci LA; Birrer M
J Mol Diagn; 2015 Jul; 17(4):374-81. PubMed ID: 25937617
[TBL] [Abstract][Full Text] [Related]
18. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.
Graff RE; Pettersson A; Lis RT; DuPre N; Jordahl KM; Nuttall E; Rider JR; Fiorentino M; Sesso HD; Kenfield SA; Loda M; Giovannucci EL; Rosner B; Nguyen PL; Sweeney CJ; Mucci LA;
Prostate; 2015 Jun; 75(9):897-906. PubMed ID: 25728532
[TBL] [Abstract][Full Text] [Related]
19. Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer.
Abou-Ouf H; Ghosh S; Box A; Palanisamy N; Bismar TA
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1751-1759. PubMed ID: 31129769
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
